"Leukemia, Lymphoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
| Descriptor ID |
D007945
|
| MeSH Number(s) |
C04.557.337.428 C15.604.515.560 C20.683.515.528
|
| Concept/Terms |
Leukemia, Lymphoid- Leukemia, Lymphoid
- Leukemias, Lymphoid
- Lymphoid Leukemias
- Lymphocytic Leukemia
- Lymphoid Leukemia
- Leukemia, Lymphocytic
- Leukemias, Lymphocytic
- Lymphocytic Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Lymphoid".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Lymphoid".
This graph shows the total number of publications written about "Leukemia, Lymphoid" by people in this website by year, and whether "Leukemia, Lymphoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Lymphoid" by people in Profiles.
-
T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years. Leuk Res. 2007 Jul; 31(7):939-45.
-
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias. Leukemia. 2005 Sep; 19(9):1567-72.
-
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine). Blood. 2005 Dec 15; 106(13):4253-60.
-
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. Leuk Res. 2003 Dec; 27(12):1077-83.
-
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate. Haematologica. 2003 Aug; 88(8):853-63.
-
Clinical activity of arsenic trioxide in Burkitt-like lymphoma. Leukemia. 2003 Jan; 17(1):271-2.
-
Leukemic mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases. Mod Pathol. 2001 Nov; 14(11):1133-40.
-
Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis. 2001 Feb 15; 32(4):539-45.
-
Nonmammary malignancies of the breast: ultrasound, CT, and MRI. Semin Ultrasound CT MR. 2000 Oct; 21(5):375-94.
-
Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies. Bone Marrow Transplant. 1999 Oct; 24(7):735-9.